CathRx sells first product to Europe
Wednesday, 17 September, 2008
CathRx [ASX: CXD] has secured the first sales of its diagnostic modular heart catheters to its UK distributor, in the company's first ever sale to Europe.
Cardiac catheters are minimally invasive tools widely used by specialist cardiologists to help diagnose and treat different types of cardiac arrhythmias.
The global market for cardiac catheters is predicted to be around $1.25 billion, with the European market alone worth $333.2 million.
CathRx plans to offer a progressively-expanding 'toolbox' of heart surgery tools to the European market in the next three quarters.
Real-time sequencing helps combat golden staph infections
Tracking bacterial changes during serious Staphylococcus aureus (golden staph) infection...
Single-cell sequencing capability boosted in South Australia
The South Australian Genomics Centre has become the first certified service provider in...
Biomaterial helps to reverse aging in the heart
The discovery could open the door to therapies that rejuvenate the heart by changing its cellular...
